At MINERVA 24, we utilize our deep scientific knowledge to help investors better understand and predict outcomes within the Biotechnology industry.
We initiate and develop fruitful partnerships to better understand our clients' needs. This results in tailored, comprehensive recommendations that improve our clients' investment strategies.
By scrutinizing a drug's development from the lab to the clinic, we gain molecular, pharmacokinetic, and pharmacodynamic insights. This allows us to better anticipate efficacy and adverse event profiles. Additionally, we apply the same approach to interpret unexpected outcomes so clients can better position their investments for success.
We have completed projects encompassing various aspects of Biotechnology:
- Drug Development
- Industry Trends & Forecasts
- Platform Utility
- Regulatory Hurdles
- Competitive Landscape
To learn more about what we do or inquire about our work, email us at
inquiry.minerva24@gmail.com
Company Details
- Founded
- -
- Address
- Boonton, New Jersey 07005, Us
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- HQ
- Boonton, New Jersey
Minerva 24 Llc. Questions
Minerva 24 Llc.'s LinkedIn profile is https://www.linkedin.com/company/minerva-24
Minerva 24 Llc.'s industry is
Business Consulting and Services
Minerva 24 Llc.'s top competitors are
Ashler Capital,
Helixnano,
Scribe Therapeutics,
Point72,
1435 Capital Management.
Minerva 24 Llc.'s categories are Business Consulting and Services
Minerva 24 Llc.'s founding year is 2020
